Documentary explores real psychedelic experiences

A new documentary titled Peaking: Psychedelics and the Pursuit of Happiness is set to premiere in Portland, offering a raw look at the effects of psychedelics on mental health. Running from September 24 to October 1 at Cinema 21, the film captures real experiences with substances like LSD, psilocybin, ibogaine, MDMA, ayahuasca, and 5-MeO-DMT, according to Willamette Week.

What the documentary explores

Peaking delves into the therapeutic potential of psychedelics, showcasing the journeys of individuals seeking relief from conditions such as trauma, depression, and substance abuse. The filmmakers interviewed participants before, during, and after their psychedelic experiences to assess the impact and longevity of the effects.

Historical and legal context

The documentary also examines the history of psychedelic criminalization and legalization in the United States. Director Jordan Kronick, known for his work on Real Sports With Bryant Gumbel, approaches the subject with a journalistic lens, aiming to provoke an emotional response from viewers by highlighting the personal stories of those undergoing these transformative experiences.

Notable participants and settings

The filmmakers traveled to various locations significant to each psychedelic, including the Amazon rainforest in Peru for ayahuasca and Mexico for ibogaine. In Oregon, the first U.S. state to legalize psilocybin in 2020, former NHL player Stephen Johns uses the substance to address traumatic brain injuries. Another former NHL player, Daniel Carcillo, who has also used psilocybin for brain injury recovery, will attend the premiere to share his experiences.

Why it matters

The documentary provides a unique perspective on the potential of psychedelics as therapeutic tools, offering insights into their impact on mental health. By presenting real-life experiences, Peaking contributes to the ongoing conversation about the role of psychedelics in modern medicine and their potential to transform mental health treatment.

Director Kronick emphasizes the intensity of some psychedelic experiences, particularly with 5-MeO-DMT, known as the 'Mount Everest of psychedelics.' He describes it as a profound experience where consciousness shifts dramatically, highlighting the diverse effects of different substances.

Peaking aims to inform both those curious about psychedelics and those already familiar with their use, providing a comprehensive look at their potential benefits and challenges.